Event Abstract

Cytogenetic safety of hBT-MSCs after long-term cryopreservation

  • 1 Kitasato University School of Medicine, Department of Plastic and Aesthetic Surgery, Japan

Statement of Purpose: We are involved in the research and development of bone substitutes using tissue engineering with the aim of decreasing the level of surgical invasion for patients requiring multiple bone transplants. We reported excellent osteogenic capability of porous HA and hybrid-type bone substitute,and we believe that our hybrid-type bone substitute can be adapted for future clinical application. We  evaluate  osteogenic  potential,  multipotency  and  the  safety  of  the  human   bone-tissue  derived  mesenchymal  stromal  cells  (hBT-MSCs)  cryopreserved 10 or more years.

Methods: We used MSCs that had undergone long-term cryopreservation at −80°C. The cells had originally been obtained after primary culture of the surplus iliac bone tissue collected during secondary bone grafting of cleft lip and palate patients performed in the Department of Plastic and Cosmetic Surgery at the Kitasato University School of Medicine.In  this  study,  cryopreserved  specimens  of  bone  tissue-derived  mesenchymal  cells  in  our  departmental  stock  were  used.  Of  the  available  specimens,  9  had  been  stored  for  10  or  more  years. 9 samples were obtained from 3 male and 6 female patient aged 5­–37 years (mean age: 12.7 years). No subjects had any infections or diseases of note.   We recultured hBM-MSCs in vitro following cryopreservation for ≥10 years, divided the cells into osteogenic differentiation and nondifferentiation MSC groups, and compared the cells in the two groups. we  assessed  in vivo  assays  regarding  osteogenic  potential  as  well  as  in  vitro  experiments  regarding  time-dependent  changes  in  bone  markers   following   osteogenic  differentiation.  As  an  indicator  of  multipotency,  the cryopreserved  hBT-MSCs  were  examined  for  adipogenic  differentiation.  Furthermore, We  made a Hybrid-type bone substitute in vivo, and the mouse back transplanted into  subcutaneous  of  back  of   8  week  old  male   nude  rats and confirmed tumorigenic presence six months later (Figure 1 Transplantation into nude rats ).

Results: There are significantly more high ALP activity and calcium-producing capability.  We accepted deletion in the CGH method in 1 specimen and accepted the inversion of the chromosome by the G-band method in the same part. The morphologic and gene abnormality were not accepted by cryopreserved hBT-MSCs except one case (Figure 2. Six months after the transplant procedure.A, B. Hybrid-type bone substitute grafting.

C. Control., Figure 3. Histological staining.

Hybrid-type bone substitute grafting.(case 4)

B.    Hybrid-type bone substitute grafting.(case 6)

C.    Hybrid-type bone substitute grafting.(case 9)

D.    Control)

Conclusions:  G-band methods is one of important techniques for the purpose of check of cytogenetic safety.  With  hBM-MSCs  cryopreserved  more  than  ten  years,  osteogenic  potential  and  multipotency  were  maintained.  The  hBT-MSCs  cryopreserved  more  than  ten  years  may  be  clinically  useful.

References:
[1] Takayuki Sugimoto. J Oral Tissue Engin 2013; 11(2):1-10
[2] Matsuo Aoi. J Craniofac Surg 2008; 19:693-700
[3] Takase Chikara. Kitasato Med J 2010; 40: 122-128

Keywords: Bone Regeneration, Bone graft, Bone repair

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Biomaterials in constructing tissue substitutes

Citation: Sugimoto T, Yamazaki Y, Kumazawa K, Sone Y and Takeda A (2016). Cytogenetic safety of hBT-MSCs after long-term cryopreservation. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02751

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.